Issue 002 | U.S. Pilot | US

OKUR

OnKure Therapeutics, Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-05 Filing currency: USD

Open Filing Back to Register Report a correction

Internal NCAV Discount 68.6%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets: 197,482,000USD
Total Liabilities: 14,341,000USD
NCAV: 183,141,000USD
Cash: 192,106,000USD
NCAV per share: 4.53USD/share
Evidence: 5 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis Normalized to latest verified split basis As reported in each filing

Metric	2026-03-31 10-Q Open filing	2025-12-31 10-K Open filing	2025-09-30 10-Q Open filing	2025-06-30 10-Q Open filing	2025-03-31 10-Q Open filing	2024-12-31 10-K Open filing	2024-09-30 10-Q Open filing	2024-06-30 10-Q Open filing	2024-03-31 10-Q Open filing	2023-12-31 10-K Open filing	2023-09-30 10-Q Open filing	2023-06-30 10-Q Open filing	2023-03-31 10-Q Open filing	2022-12-31 10-K Open filing	2022-09-30 10-Q Open filing	2022-06-30 10-Q Open filing	2022-03-31 10-Q Open filing	2021-12-31 10-K Open filing	2021-09-30 10-Q Open filing	2021-06-30 10-Q Open filing
Period-end Shares Outstanding	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	1,334,71213,347,117	334,3523,343,525	n/an/a	n/an/a	3,342,08133,420,808	3,387,21733,872,166	3,380,07933,800,788	2,510,74325,107,430	2,469,95524,699,553	2,452,96524,529,646	2,447,96524,479,646	2,445,85524,458,550	2,445,53924,455,390	2,440,77224,407,722	2,428,87024,288,699
Weighted-average Basic Shares	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	334,2823,342,824	3,342,08133,420,808	3,342,08133,420,808	n/an/a	2,447,29724,472,974	2,446,10824,461,085	n/an/a	n/an/a	n/an/a	n/an/a	2,445,82924,458,290	1,814,34918,143,487	n/an/a	n/an/a
Weighted-average Diluted Shares	13,674,57713,674,577	13,515,91513,515,915	1,353,08913,530,892	1,350,90813,509,080	1,342,43413,424,335	344,7073,447,071	338,0793,380,794	3,021,53230,215,321	2,503,64125,036,410	3,067,64630,676,455	3,380,79433,807,945	3,021,53230,215,321	2,503,64125,036,410	2,449,64224,496,425	2,449,63124,496,313	2,446,38224,463,824	2,445,82924,458,290	1,814,34918,143,487	n/an/a	n/an/a
Basic EPS	-1-1	-4-4	-3-3	-2-2	-1-1	-15-15	-5-5	-0-0	-0-0	-3-3	-2-2	-1-1	-1-1	-2-2	-2-2	-1-1	-1-1	-2-2	-2-2	-1-1
Diluted EPS	-1-1	-4-4	-3-3	-2-2	-1-1	-15-15	-5-5	-0-0	-0-0	-3-3	-2-2	-1-1	-1-1	-2-2	-2-2	-1-1	-1-1	-2-2	-2-2	-1-1
Basic-to-Diluted Share Difference	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	1.1%	-9.6%	-25.1%	Insufficient evidence	38.1%	23.5%	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	0.0%	0.0%	Insufficient evidence	Insufficient evidence
Net Share Count Change	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	299.2%	Insufficient evidence	0.0%	Insufficient evidence	-1.3%	0.2%	34.6%	1.7%	0.7%	0.2%	0.1%	0.0%	0.2%	0.5%	Insufficient evidence
Ownership Claim Change	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	-74.9%	Insufficient evidence	0.0%	Insufficient evidence	1.4%	-0.2%	-25.7%	-1.6%	-0.7%	-0.2%	-0.1%	-0.0%	-0.2%	-0.5%	Insufficient evidence

Verified split events: reverse 4.4748 on 2021-04-05; reverse 10.0 on 2025-12-31

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric	2025-12-31 10-K USD	2024-12-31 10-K USD	2023-12-31 10-K USD	2022-12-31 10-K USD	2021-12-31 10-K USD
Revenue	n/a	0	n/a	n/a	n/a
Operating Income	-62,950,000	-54,386,000	-83,053,000	-53,848,000	-39,818,000
Net Income	-59,517,000	-52,673,000	-77,388,000	-51,955,000	-39,770,000
Cash From Operations	-51,828,000	-51,117,000	-63,682,000	-47,362,000	-37,983,000
Capex	-46,000	-52,000	-221,000	-346,000	-198,000
Free Cash Flow	-51,874,000	-51,169,000	-63,903,000	-47,708,000	-38,181,000
Cash And Equivalents	59,050,000	110,761,000	27,632,000	19,927,000	124,660,000
Accounts Receivable	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Total Current Assets	60,839,000	113,003,000	106,622,000	106,353,000	153,734,000
Total Assets	62,117,000	114,907,000	107,436,000	108,182,000	154,024,000
Total Current Liabilities	5,921,000	10,530,000	18,177,000	7,124,000	6,202,000
Total Liabilities	5,933,000	11,079,000	18,826,000	8,212,000	6,813,000
Shareholders Equity	56,184,000	103,828,000	88,610,000	99,970,000	147,211,000
Shares Outstanding	13,673,565	1,334,712	3,342,081	2,510,743	2,445,855
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	13,515,915	344,707	283,817	2,449,642	1,814,349
Weighted Avg Shares Basic	13,515,915	344,707	283,817	2,449,642	1,814,349
Net Share Count Change (Normalized)	Insufficient evidence	299.2%	-1.3%	0.7%	0.2%
Ownership Claim Change (Normalized)	Insufficient evidence	-74.9%	1.4%	-0.7%	-0.2%

Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric	2026-03-31 10-Q USD	2025-12-31 10-K USD	2025-09-30 10-Q USD	2025-06-30 10-Q USD	2025-03-31 10-Q USD	2024-12-31 10-K USD	2024-09-30 10-Q USD	2024-06-30 10-Q USD	2024-03-31 10-Q USD	2023-12-31 10-K USD	2023-09-30 10-Q USD	2023-06-30 10-Q USD	2023-03-31 10-Q USD	2022-12-31 10-K USD	2022-09-30 10-Q USD	2022-06-30 10-Q USD	2022-03-31 10-Q USD	2021-12-31 10-K USD	2021-09-30 10-Q USD	2021-06-30 10-Q USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-15,615,000	-14,125,000	-15,501,000	-16,324,000	-17,000,000	-33,794,000	-4,664,000	-6,364,000	-9,564,000	-25,003,000	-20,888,000	-21,039,000	-16,123,000	-14,562,000	-13,840,000	-12,431,000	-13,015,000	-10,624,000	-12,752,000	-9,228,000
Net Income	-15,157,000	-13,503,000	-14,699,000	-15,390,000	-15,925,000	-35,194,000	-3,692,000	-5,361,000	-8,426,000	-23,554,000	-19,196,000	-19,531,000	-15,107,000	-13,600,000	-13,007,000	-12,312,000	-13,036,000	-10,607,000	-12,735,000	-9,216,000
Cash From Operations	-12,938,000	-11,512,000	-13,037,000	-13,274,000	-14,005,000	-21,015,000	-2,281,000	-6,807,000	-21,014,000	-19,753,000	-18,767,000	-16,114,000	-9,048,000	-15,613,000	-10,794,000	-11,956,000	-8,999,000	-10,021,000	-9,672,000	-9,701,000
Capex	-5,000	-9,000	-6,000	-13,000	-18,000	-50,000	0	7,000	-9,000	-25,000	-19,000	-5,000	-172,000	-250,000	-28,000	-24,000	-44,000	-90,000	-77,000	-6,000
Free Cash Flow	-12,943,000	-11,521,000	-13,043,000	-13,287,000	-14,023,000	-21,065,000	-2,281,000	-6,800,000	-21,023,000	-19,778,000	-18,786,000	-16,119,000	-9,220,000	-15,863,000	-10,822,000	-11,980,000	-9,043,000	-10,111,000	-9,749,000	-9,707,000
Cash And Equivalents	192,106,000	59,050,000	70,331,000	83,374,000	96,661,000	110,761,000	60,689,000	35,970,000	20,375,000	27,632,000	11,737,000	9,081,000	30,395,000	19,927,000	62,132,000	118,264,000	121,094,000	124,660,000	126,409,000	140,368,000
Total Current Assets	197,482,000	60,839,000	71,526,000	84,552,000	98,172,000	113,003,000	76,999,000	77,990,000	83,927,000	106,622,000	128,772,000	146,320,000	97,018,000	106,353,000	120,998,000	132,011,000	142,715,000	153,734,000	162,665,000	171,141,000
Total Liabilities	14,341,000	5,933,000	6,407,000	7,904,000	9,234,000	11,079,000	3,627,000	1,848,000	3,397,000	18,826,000	15,444,000	15,511,000	11,784,000	8,212,000	10,459,000	9,451,000	9,094,000	6,813,000	6,735,000	3,753,000
Shares Outstanding	40,395,480	13,673,565	n/a	n/a	n/a	13,347,117	334,352	3,342,881	3,342,081	3,342,081	3,331,179	3,380,079	3,365,512	2,510,743	2,452,965	2,447,965	2,445,855	2,445,855	2,442,390	2,440,533
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	13,674,577	13,597,288	1,353,089	1,350,908	1,342,434	3,447,071	316,142	315,478	314,016	3,351,852	3,380,794	3,021,532	2,503,641	2,456,609	2,449,631	2,446,382	2,445,829	2,442,745	2,439,680	2,136,437
Weighted Avg Shares Basic	13,674,577	13,597,288	1,353,089	1,350,908	1,342,434	3,447,071	316,142	315,478	314,016	3,351,852	3,380,794	3,021,532	2,503,641	2,456,609	2,449,631	2,446,382	2,445,829	2,442,745	2,439,680	2,136,437
Net Share Count Change (Normalized)	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	299.2%	Insufficient evidence	0.0%	Insufficient evidence	-1.3%	0.2%	34.6%	1.7%	0.7%	0.2%	0.1%	0.0%	0.2%	0.5%	Insufficient evidence
Ownership Claim Change (Normalized)	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	-74.9%	Insufficient evidence	0.0%	Insufficient evidence	1.4%	-0.2%	-25.7%	-1.6%	-0.7%	-0.2%	-0.1%	-0.0%	-0.2%	-0.5%	Insufficient evidence

Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input	Value	Source concept	Filing period	Confidence	Provenance
Current Assets	197,482,000USD	us-gaap:AssetsCurrent	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001637715/companyfacts.json Data Vault \| sec/companyfacts/cik=0001637715/companyfacts.json
Total Liabilities	14,341,000USD	us-gaap:Liabilities	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001637715/companyfacts.json Data Vault \| sec/companyfacts/cik=0001637715/companyfacts.json
Cash	192,106,000USD	us-gaap:CashAndCashEquivalentsAtCarryingValue	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001637715/companyfacts.json Data Vault \| sec/companyfacts/cik=0001637715/companyfacts.json
Shares Outstanding	40,395,480	dei:EntityCommonStockSharesOutstanding	2026-03-31	1.00	n/a
NCAV	183,141,000USD	derived	2026-03-31	n/a	company-evidence-v1 \| total_current_assets - total_liabilities
NCAV per share	4.53USD	derived	2026-03-31	n/a	company-evidence-v1 \| NCAV / shares_outstanding
Internal NCAV Discount	68.6%	derived	2026-03-31	n/a	gnni_publication_pack \| internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source: Data Vault
Data Vault Root: Local evidence | The Data Vault
CIK: 0001637715
Company ID: n/a
Selected Annual Source: Data Vault | sec/companyfacts/cik=0001637715/companyfacts.json
Selected Quarterly Source: Data Vault | sec/companyfacts/cik=0001637715/companyfacts.json
Statement Extractor: companyfacts-screener-v1
View Extractor: companyfacts-screener-v1
Source Accession Count: 21
Imported At: 2026-08-15T12:52:36+00:00
Rendered At: 2026-08-16T03:29:43+00:00

Run Audit

Mary Run: f75c5d221f074da8a489fba328e8ef51
Mary As Of: 2026-07-18
Accession: 0001193125-26-206345
CIK: 0001637715
Mary Filing Date: 2026-05-05
Filing Currency: USD
Internal Discount: 68.6%
Source State: Verified
Market Context: Not Displayed
Market Policy: internal_only_not_redistributed
Share Trend: Not Evaluated
Dilution: Needs Review

mary_run=f75c5d221f074da8a489fba328e8ef51; mary_as_of=2026-07-18; mary_filing_date=2026-05-05; mary_accession=0001193125-26-206345; mary_cik=0001637715; gnni_supporting_filing_date=2026-05-05; internal_discount=0.686399; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive